Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126505) titled 'Study on the efficacy and safety of Loncipoetin alfa Injection in the treatment of anemia in patients with ESRD undergoing initial dialysis' on June 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Condition:
Anemia
Intervention:
Loncipoetin alfa Injection (SSS06) QOW Group:Loncipoetin alfa Injection
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-07-01
Target Sample Size: Loncipoetin alfa Injection (SSS06) QOW Group:107;Recombinant Human Erythropoietin Injection (CHO Cell) Group:...